Neural or "Moral" therapy in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients

Abstract

We have taken interest in the recently published article byTamam et al1in theNeurourol Urodyn. The authorsretrospectively evaluated the effects of neural therapy (NT) in multiple sclerosis (MS) patients.

Although we congratulatethe authors for their hard work, we would like to comment onsome major concerns for this article.